

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Sestamibi
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Undisclosed
Sponsor : Edwin Wu
Deal Size : Inapplicable
Deal Type : Inapplicable
Half-Dose Radiopharmaceutical in Wide Beam Reconstruction
Details : Cardiolite (99m-Tc Sestamibi) is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Myocardial Infarction.
Product Name : Cardiolite
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 26, 2011
Lead Product(s) : Sestamibi
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Undisclosed
Sponsor : Edwin Wu
Deal Size : Inapplicable
Deal Type : Inapplicable
